skip to main
|
skip to sidebar
biosink
7.26.2007
Fresh from the FDA Dockets (DrugWonks)
Fresh from the FDA Dockets (DrugWonks)
: "This from the Glaxo data submission. I can bet you won't see this reported anywhere else:"
Newer Post
Older Post
Home
Blog Archive
►
2013
(14)
►
05/05 - 05/12
(1)
►
04/07 - 04/14
(9)
►
03/31 - 04/07
(1)
►
03/10 - 03/17
(3)
►
2010
(4)
►
06/13 - 06/20
(1)
►
01/31 - 02/07
(2)
►
01/10 - 01/17
(1)
►
2009
(22)
►
09/20 - 09/27
(2)
►
09/06 - 09/13
(1)
►
08/09 - 08/16
(1)
►
08/02 - 08/09
(1)
►
07/12 - 07/19
(1)
►
05/10 - 05/17
(2)
►
04/19 - 04/26
(5)
►
04/12 - 04/19
(1)
►
04/05 - 04/12
(7)
►
03/01 - 03/08
(1)
►
2008
(290)
►
12/28 - 01/04
(2)
►
12/21 - 12/28
(4)
►
12/14 - 12/21
(2)
►
11/23 - 11/30
(1)
►
10/26 - 11/02
(5)
►
10/19 - 10/26
(5)
►
10/12 - 10/19
(55)
►
10/05 - 10/12
(1)
►
09/28 - 10/05
(1)
►
09/21 - 09/28
(45)
►
09/14 - 09/21
(3)
►
08/31 - 09/07
(5)
►
08/24 - 08/31
(20)
►
08/17 - 08/24
(3)
►
08/10 - 08/17
(1)
►
08/03 - 08/10
(3)
►
07/13 - 07/20
(1)
►
07/06 - 07/13
(2)
►
06/29 - 07/06
(13)
►
06/15 - 06/22
(2)
►
06/08 - 06/15
(2)
►
06/01 - 06/08
(2)
►
05/25 - 06/01
(7)
►
05/18 - 05/25
(7)
►
05/11 - 05/18
(1)
►
04/27 - 05/04
(9)
►
04/20 - 04/27
(22)
►
04/13 - 04/20
(11)
►
04/06 - 04/13
(20)
►
03/30 - 04/06
(4)
►
03/23 - 03/30
(1)
►
03/16 - 03/23
(1)
►
03/09 - 03/16
(1)
►
02/24 - 03/02
(3)
►
02/17 - 02/24
(10)
►
02/10 - 02/17
(5)
►
02/03 - 02/10
(2)
►
01/27 - 02/03
(3)
►
01/13 - 01/20
(4)
►
01/06 - 01/13
(1)
▼
2007
(1218)
►
12/16 - 12/23
(4)
►
12/02 - 12/09
(5)
►
11/25 - 12/02
(4)
►
11/18 - 11/25
(22)
►
11/11 - 11/18
(31)
►
11/04 - 11/11
(10)
►
10/28 - 11/04
(4)
►
10/21 - 10/28
(15)
►
10/14 - 10/21
(31)
►
10/07 - 10/14
(85)
►
09/30 - 10/07
(129)
►
09/23 - 09/30
(23)
►
09/16 - 09/23
(98)
►
09/09 - 09/16
(116)
►
09/02 - 09/09
(52)
►
08/26 - 09/02
(57)
►
08/19 - 08/26
(52)
►
07/29 - 08/05
(40)
▼
07/22 - 07/29
(173)
Patent Docs: Biosimilars 2007 Conference
Patent Docs: Ranbaxy and GlaxoSmithKline Settle Va...
BioCryst Initiates Phase II Clinical Trial to Eval...
Sector Glance: Biotechnology - Forbes.com
Patent Law Jobs by Patently-O: Patent Counsel - Me...
Xconomy � Blog Archive � Reeves to Menino: Cambrid...
FDA Reviewer Rips Nissens (DrugWonks)
Health Blog : Merck's Vioxx Warrior Gets Promoted
Patent Prospector: Scratch & Sniff
Have I Been Misreading the FDA? (DrugWonks)
Sector Glance: Biotechnology - Forbes.com
Neogen Announces 3-for-2 Stock Split
Health Blog : FDA Committee Won't Consider Controv...
The Volokh Conspiracy - Lawsuit Challenging Qualif...
: "NEW DELHI: Riding on the success of Bt cotton, ...
Biolex Therapeutics Announces Positive Phase 2a Re...
Threshold Pharmaceuticals Initiates Phase 1 Clinic...
EntreMed Commences Leukemia Clinical Trial for MKC...
Peter Zura's 271 Patent Blog: Manufacturing and La...
FDA Drug Approval Statistics
Patent Prospector: Laboring over Patent Reform
Biotech Blog � Expanding the bandwidth of life sci...
Fresh from the FDA Dockets (DrugWonks)
Patent Law Blog (Patently-O): No Revival For "Unin...
Aspreva cuts a quarter of its jobs as it refocuses...
ADA Applauds Legislators for 'Meth Mouth' Bills
Cell Therapeutics inks deal to buy cancer drug dev...
Pfizer, Hydra strike $195M pain pact - FierceBiote...
Biotech CEOs face rising fury of angry investors -...
Faster, Easier Quantification of Secreted IgG Anti...
New compounds in works for tuberculosis - FierceBi...
Scientists plot first moves for Project Checkmate ...
Synthetic biology spawns fresh approach to antibio...
ALSO NOTED: Fat cells could be used to replace sil...
Reduced insulin signaling may halt aging, disease ...
Patch to replace heart transplants? - FierceBioRes...
ALSO NOTED: Geron faces critics' wrath;New diagnos...
Health Blog : An Ugly Saga of Politics and AIDS Wi...
Health Blog : Drug Companies Seize Tax Break, Cut ...
Health Blog : Japanese Takeout: Drug Making
ALSO NOTED: Advanced Magnetics touts Phase III dat...
Press Release: BioXell To Regain Rights To TREM Pl...
Health Blog : FDA Delays Decision on Wyeth Menopau...
Biosecurity expert points to threat of smallpox at...
Venter's latest revelation could save the world - ...
Health Blog : Goldman Gets Into Hospital Software
Cell Therapeutics, Inc. Announces $20.25 Million O...
Orange Book Blog: Federal Circuit Affirms Invalidi...
Health Blog : Insurers Put Money Behind Doctor Rat...
Evogene and CIRAD Expand Their Cotton Collaboration
SignOnSanDiego.com > News > Business -- Amylin rep...
US presses ahead with patent reforms - ZDNet UK
Sector Snap: Drug Companies - Forbes.com
Patent Docs: Organon and MRC Technology to Collabo...
Patent Docs: USPTO News: Patent Office Sends KSR T...
Patent Docs: USPTO News: New Continuation and Clai...
FDA Oncologic Drugs Advisory Committee Recommends ...
MaRS Blog - Innovation and Commercialization in Ca...
Patent Prospector: Dealing with KSR
Biotech Definitions: "Biotech DefinitionsBIO-INFOM...
Biotechnology in Texas
Protalex Announces Preliminary Results in Phase I ...
The Fire of Genius � A New Essay
Orexigen claims success in weight-loss trial - Fie...
Big Pharma brings home the cash, slices payroll - ...
New hope for cross-species transplantation - Fierc...
Controlling brain protein may modulate stress, moo...
Biotech pioneer bets a billion on Alzheimer's prog...
FDA demands more data on Wyeth's Pristiq - FierceB...
OilOnline - The Original Online Source for the Oil...
Alzheimer's Drug Discovery Foundation Invites Scie...
Fourth ACTEMRA(TM) (tocilizumab) Phase III Study D...
IPOX Schuster's New China IPO Index Focused On 'A'...
PharmaLive: DSM Biologics and Crucell Announce PER...
From the Sequencer to the Drugstore?. In the Pipel...
Patent Prospector: USPTO Rule Changes
Health Blog : The Science of Peppers and Pain
Pharma Marketing Blog: Why Do DTC Ads - "Viva Viag...
Health Blog : Glaxo's Earnings Steady, Despite Ava...
Patent Prospector: Silk Purse from a Sow's Ear
News: Arena Pharmaceuticals Initiates Phase 1 Clin...
A Farewell to Tin. In the Pipeline:
ScienceDaily: Study Urges Compensation-based Appro...
Health Blog : Building Family-Friendly ICUs
Want To Live Longer? Take New Drugs (DrugWonks)
Bioethics Crisis in China
News: Scientists Find Compound that Targets Therap...
Biotech Blog � Drug reimportation: Where are the d...
QLT announces FDA filing and review of Aczone(TM) ...
EpiCept Announces Phase III Study of EpiCept(TM) N...
GeekPress
SPOTLIGHT: Targeted Genetics study on hold - Fierc...
Anticipate This! EP-Oh! (Information about the Eur...
Patent Docs: Mergers and Acquisitions Are Preferre...
The IN VIVO Blog
Health Blog : Lab Values Predict Mortality for Hos...
Genstar inks $744M deal to buy PRA International -...
WuXi PharmaTech files $120M IPO on NYSE - FierceBi...
China pushes drug development as R&D soars - Fierc...
Merck snares NovaCardia in $350M buyout - FierceBi...
►
07/15 - 07/22
(24)
►
07/08 - 07/15
(10)
►
05/06 - 05/13
(7)
►
04/29 - 05/06
(76)
►
04/22 - 04/29
(150)